|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss for the year | ||
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Stock-based compensation expense | ||
| Non-cash interest expense | ||
| Change in operating lease right-of-use assets | ||
| Change in fair value of debentures | ||
| Loss of extinguishment of debentures | ||
| IPR&D - Teverelix | ||
| Foreign exchange gain/loss | ||
| Loss on SEPA settlements | ||
| Issuance cost related to SEPA | ||
| Cost of issuance of debentures | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Deferred financing costs | ||
| Accounts payable | ||
| Accrued expenses and other current liabilities | ||
| Operating lease liability | ||
| Related party payable | ||
| Net cash used in operating activities | ||
| Cash flows from financing activities | ||
| Proceeds from issuance of convertible promissory notes | ||
| Proceeds from initial public offering, net of offering expenses | ||
| Proceeds from issuance of common shares and warrants, net of issuance costs | ||
| Proceeds from concurrent financing | ||
| Proceeds from issuance of debentures | ||
| Repayment of the debentures and other loan | ||
| Proceeds from issuance of common shares under SEPA | ||
| Proceeds from exercise of warrants | ||
| Proceeds from exercise of stock options | ||
| Costs to issue debentures | ||
| Issuance costs for common shares | ||
| Net cash provided by financing activities | ||
| Cash flows from investing activities | ||
| Net cash paid for Antev asset acquisition including transaction costs | ||
| Net cash used in investing activities | ||
| Foreign currency effect on cash and cash equivalents | ||
| Net increase in cash and cash equivalents during the year | ||
| Cash and cash equivalents, beginning of the year | ||
| Cash and cash equivalents, end of the year | ||
| Supplemental information | ||
| Cash paid for interest | ||
| Supplemental disclosure of non-cash investing and financing activities | ||
| Right-of-use assets obtained in exchange for lease liabilities | ||
| Deemed dividend on warrant inducement | ||
| Issuance costs included in accounts payable | ||
| Shares issued for Antev asset acquisition | ||
| Shares to be issued for Antev asset acquisition | ||
| Issuance of shares related to SEPA agreement | ||
| Accrued interest converted into common shares |
Loading...
